Dimensional Fund Advisors’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
1,048,936
+381,437
| +57% | +$5M | ﹤0.01% | 2141 |
|
|
2025
Q1 | $14.7M | Sell |
667,499
-62,424
| -9% | -$1.37M | ﹤0.01% | 2085 |
|
|
2024
Q4 | $19.5M | Buy |
729,923
+3,052
| +0.4% | +$81.5K | ﹤0.01% | 2003 |
|
|
2024
Q3 | $19.4M | Buy |
726,871
+259,364
| +55% | +$6.92M | ﹤0.01% | 2018 |
|
|
2024
Q2 | $8.42M | Buy |
467,507
+168,219
| +56% | +$3.03M | ﹤0.01% | 2331 |
|
|
2024
Q1 | $5.46M | Buy |
299,288
+37,050
| +14% | +$676K | ﹤0.01% | 2526 |
|
|
2023
Q4 | $2.87M | Buy |
262,238
+87,317
| +50% | +$956K | ﹤0.01% | 2706 |
|
|
2023
Q3 | $1M | Buy |
174,921
+101,863
| +139% | +$584K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $566K | Buy |
73,058
+45,775
| +168% | +$354K | ﹤0.01% | 3038 |
|
|
2023
Q1 | $182K | Buy |
27,283
+1,091
| +4% | +$7.28K | ﹤0.01% | 3221 |
|
|
2022
Q4 | $235 | Buy |
26,192
+12
| +0% | – | ﹤0.01% | 3196 |
|
|
2022
Q3 | $258K | Buy |
+26,180
| New | +$258K | ﹤0.01% | 3194 |
|